SIRI and SII, which are usually assessed based on peripheral blood-based parameters (e.g., lymphocytes, CRP, monocytes, neutrophils, or PLT count), have been shown to be associated with several types of cancer [22,23]. The gene discussed is CRP; the disease is cancer.